Model of effect of magnesium prophylaxis on frequency of torsades de pointes in ibutilide-treated patients

Am J Health Syst Pharm. 2004 Apr 1;61(7):685-8. doi: 10.1093/ajhp/61.7.685.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study

MeSH terms

  • Aged
  • Aged, 80 and over
  • Anti-Arrhythmia Agents / adverse effects*
  • Female
  • Humans
  • Magnesium / therapeutic use*
  • Male
  • Middle Aged
  • Monte Carlo Method
  • Sulfonamides / adverse effects*
  • Torsades de Pointes / prevention & control*
  • United States

Substances

  • Anti-Arrhythmia Agents
  • Sulfonamides
  • ibutilide
  • Magnesium